Pyocyanin Alters Redox Homeostasis and Carbon Flux through Central Metabolic Pathways in Pseudomonas aeruginosa PA14 by Price-Whelan, Alexa et al.
JOURNAL OF BACTERIOLOGY, Sept. 2007, p. 6372–6381 Vol. 189, No. 17
0021-9193/07/$08.000 doi:10.1128/JB.00505-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Pyocyanin Alters Redox Homeostasis and Carbon Flux through
Central Metabolic Pathways in Pseudomonas aeruginosa PA14†
Alexa Price-Whelan,1 Lars E. P. Dietrich,2,3 and Dianne K. Newman1,2,3*
Divisions of Biology1 and Geological and Planetary Sciences2 and Howard Hughes Medical Institute,3
California Institute of Technology, Pasadena, California 91125
Received 2 April 2007/Accepted 15 May 2007
The opportunistic pathogen Pseudomonas aeruginosa produces colorful, redox-active antibiotics called
phenazines. Excretion of pyocyanin, the best-studied natural phenazine, is responsible for the bluish tint of
sputum and pus associated with P. aeruginosa infections in humans. Although the toxicity of pyocyanin for
other bacteria, as well as its role in eukaryotic infection, has been studied extensively, the physiological
relevance of pyocyanin metabolism for the producing organism is not well understood. Pyocyanin reduction by
P. aeruginosa PA14 is readily observed in standing liquid cultures that have consumed all of the oxygen in the
medium. We investigated the physiological consequences of pyocyanin reduction by assaying intracellular
concentrations of NADH and NAD in the wild-type strain and a mutant defective in phenazine production.
We found that the mutant accumulated more NADH in stationary phase than the wild type. This increased
accumulation correlated with a decrease in oxygen availability and was relieved by the addition of nitrate.
Pyocyanin addition to a phenazine-null mutant also decreased intracellular NADH levels, suggesting that
pyocyanin reduction facilitates redox balancing in the absence of other electron acceptors. Analysis of extra-
cellular organic acids revealed that pyocyanin stimulated stationary-phase pyruvate excretion in P. aeruginosa
PA14, indicating that pyocyanin may also influence the intracellular redox state by decreasing carbon flux
through central metabolic pathways.
Redox transformations are a defining feature of the creation
of biomass. To form precursors for incorporation into cellular
material, heterotrophic organisms catalyze the oxidation of
organic carbon sources, generating reducing power. This re-
ducing power can be released in fermentation products or
transferred to an externally supplied oxidant via the respiratory
chain. The fluid exchange of electrons between intra- and ex-
tracellular environments permits organisms to maintain a buff-
ered intracellular redox state, a condition required for the
stability and function of biological macromolecules (7, 47).
Under traditional laboratory culture conditions, electron do-
nors and acceptors are often provided in excess, allowing mi-
croorganisms to control intracellular redox conditions. How-
ever, it is becoming clear that energy starvation, i.e., the
limitation of substrates for oxidative or substrate-level phos-
phorylation, more closely mirrors conditions encountered by
many bacteria in their natural habitats (37). How do bacteria
maintain redox homeostasis under these conditions?
Bacteria of the genus Pseudomonas, like most heterotrophic
bacteria (12, 24), oxidize organic carbon sources via the activity
of the Entner-Doudoroff pathway and the citric acid cycle.
Several of the oxidative steps in these pathways are coupled to
the reduction of NAD to NADH, and NADH must be reoxi-
dized so that these pathways can proceed and generate ana-
bolic precursors. In pseudomonads, the primary mechanism
whereby this is accomplished is through reduction of one of the
NADH dehydrogenases at the start of the respiratory chain,
which ultimately transfers the electrons to oxygen or nitrate
(71). It has therefore been assumed that pseudomonads, or-
ganisms that rely on respiration for growth under most condi-
tions, accumulate NADH when terminal electron acceptors
become limiting.
Given that the NADH/NAD redox couple plays a major
role in central metabolism, the ratio of the reduced form to the
oxidized form is thought to be representative of the intracel-
lular redox state (16). In previous studies, measurements of the
NADH/NAD ratio in a variety of bacterial species have dis-
tinguished the opportunistic pathogen Pseudomonas aerugi-
nosa from organisms such as Clostridium welchii, Klebsiella
aerogenes, Escherichia coli, and Staphylococcus albus as the
only species with a steady-state NADH/NAD ratio greater
than 1 (73). However, another characteristic feature of some
pseudomonad strains, which distinguishes them from all of the
other genera mentioned above, is the ability to produce redox-
active antibiotics known as phenazines (44). Some of these
compounds, including pyocyanin, the best-studied phenazine
due to its role in the pathology of P. aeruginosa infections (38),
have been shown to react with NADH in vitro (15, 36). This
has led to the hypothesis that electron transfer to phenazines
may represent an adaptation that allows bacteria to modulate
their intracellular redox state (23, 52, 66, 67). This physiolog-
ical role would be consistent with the fact that phenazine
biosynthesis is regulated such that phenazines are produced at
high cell densities (9, 33, 51, 69), a condition that typically
correlates with electron acceptor limitation (63).
Much research has focused on the toxic effects of pyocyanin
as a virulence factor in the eukaryotic host (38, 42, 48, 56, 62)
as well as in microorganisms (2, 3, 28, 35, 55). These effects
* Corresponding author. Current address: 31 Ames St., 68-380,
Cambridge, MA 02139. Phone: (617) 324-2770. Fax: (617) 253-8699.
E-mail: dkn@mit.edu.
† Supplemental material for this article may be found at http://jb
.asm.org/.
 Published ahead of print on 25 May 2007.
6372
 at CALIFO
RNIA INSTITUTE O
F TECHNO
LO
G
Y on August 22, 2007 
jb.asm.org
D
ow
nloaded from
 
have been attributed to the production of reactive oxygen
species such as superoxide in the presence of pyocyanin (26,
27), and physiological studies have shown that P. aeruginosa
resists the toxicity of this compound with increased superoxide
dismutase and catalase activities under pyocyanin-producing
conditions (29, 30). Additionally, recent gene expression stud-
ies have uncovered a role for pyocyanin in intercellular signal-
ing (18). However, little is known about the role of this com-
pound in pseudomonad metabolism or whether P. aeruginosa
derives a benefit from the utilization of pyocyanin as an elec-
tron acceptor.
The facile reversibility of phenazine redox reactions allows
these compounds to oxidize major intracellular reductants and
subsequently reduce extracellular oxidants, thereby acting as
redox mediators (25, 31, 39, 46, 53, 61). The redox potentials of
pyocyanin and phenazine-1-carboxylic acid, the two major
phenazines produced by P. aeruginosa PA14, are 34 mV (22)
and 116 mV (Y. Wang and D. K. Newman, unpublished
data), respectively, versus the standard hydrogen electrode at
pH 7. These potentials are high enough to allow reduction by
NADH (E0  320 mV) and glutathione (E0  240 mV)
(1, 65) but low enough to allow electron transfer to environ-
mentally relevant oxidants, including oxygen, nitrate, and ferric
iron. Therefore, electron shuttling via phenazines may be a
mechanism whereby pseudomonads can utilize electron accep-
tors that, due to low concentrations or solubility, might other-
wise be inaccessible via conventional biochemical and enzy-
matic routes (13, 32, 52). The role of this electron transfer in P.
aeruginosa energy metabolism has yet to be elucidated, but
work carried out with another gammaproteobacterium, Sh-
ewanella oneidensis MR-1, indicated that phenazines, as well as
similarly structured small molecules, facilitates reduction of
insoluble ferric oxyhydroxides and stimulates growth (31, 41).
Furthermore, a critical electron carrier function has been dem-
onstrated for a membrane-bound phenazine derivative present
in the electron transport chains of methanogenic archaea (4).
In an effort to better understand the physiological significance
of phenazine reduction in pseudomonads, we characterized the
effects of pyocyanin on redox homeostasis and central metab-
olism in P. aeruginosa PA14.
MATERIALS AND METHODS
Bacterial strains and culture conditions. For this study, we used P. aeruginosa
strain UCBPP-PA14 (54), which produces approximately 10 times more pyocy-
anin in LB batch cultures than strain PAO1 (18). The P. aeruginosa PA14 mutant
containing the MAR2xT7 transposon inserted in the ldhA gene in a exoU
background was obtained from a publicly available mutant library (40) and has
mutant identification no. 5174. Generation of the P. aeruginosa PA14 phzA1-
1G1 phzA2-2G2 deletion mutant (hereafter referred to as the phz mutant) was
described previously (18). P. aeruginosa PA14 wild-type and mutant strains were
grown aerobically at 37°C in Luria-Bertani broth (Fisher Scientific), or modified
MOPS (morpholinepropanesulfonic acid) synthetic medium (50). Our modified
MOPS synthetic medium contained 50 mM MOPS (Sigma) at pH 7.2, 93 mM
NH4Cl, 43 mM NaCl, 2.2 mM KH2PO4, 1 mM MgSO4  7H2O, and 3.6 M
FeSO4  7H2O. Unless otherwise noted, 50 mM D-glucose was added to this
medium as the sole carbon and energy source. Aerobic conditions were gener-
ated either through incubation with vigorous shaking at 250 rpm or in a BioFlo
110 fermentor (New Brunswick Scientific) set to agitate at 250 rpm and bubble
with 100% air at a rate of 2 liters/minute. Aerobic culture volumes relative to
vessel size are described below for specific experiments. Culture densities were
followed at 500 or 600 nm in a Thermo Spectronic 20D or Beckman Coulter
DU 800 spectrophotometer. Cultures with optical densities of greater than 0.8
were diluted 1:10 in fresh medium to allow accurate measurements. The method
used to test strains for the ability to survive via pyruvate fermentation is de-
scribed in the supplemental material.
Preparation of pyocyanin for reduction assays and NADH/NAD studies. To
maximize pyocyanin yields from P. aeruginosa cultures, we utilized a mutant,
strain DKN370, which contains two copies of the gene phzM. PhzM converts
phenazine-1-carboxylic acid to the precursor for pyocyanin, 5-methylphena-
zinium carboxylate (45). Purification of pyocyanin by organic extractions was
carried out as described previously (18). High-pressure liquid chromatography
(HPLC) analysis verified the purity of pyocyanin after the extraction step, so the
HPLC purification step described in reference 18 was omitted. Purified pyocy-
anin was dissolved in MOPS buffer (MOPS synthetic medium without FeSO4,
MgSO4, or glucose), and filtered (0.2-m filter).
Whole-cell suspension assay for pyocyanin reduction. Cell culture samples
were concentrated or diluted in filtrates of supernatants from the same culture to
normalize the optical density at 600 nm to 0.8. In an anaerobic chamber, the
samples were transferred to cuvettes, and an anoxic solution of oxidized pyocy-
anin (in MOPS buffer) was added for a final pyocyanin concentration of about 0.1
mM. The cuvettes were stoppered to minimize oxygen exposure. Pyocyanin
reduction was then followed as a decrease in absorbance at 690 nm over time in
a DU 800 Beckman Coulter spectrophotometer. The rate of reduction could be
calculated by converting the change in absorbance to mol pyocyanin using the
extinction coefficient for pyocyanin at this wavelength (ε  4,310 M1 cm1 at
pH 7) (49) and the volume of sample in the cuvette (1 ml).
Quantification of pyocyanin. Pyocyanin concentrations in filtrates (0.2-m
pore) from LB and MOPS synthetic medium cultures were quantified as de-
scribed previously (18). Briefly, absorbance in LB culture filtrates was measured
spectrophotometrically at 690 nm, and pyocyanin concentrations were calculated
using the extinction coefficient for pyocyanin (see above). Pyocyanin concentra-
tions in 200-l sample filtrates from MOPS synthetic medium cultures were
determined by HPLC analysis on a Waters Symmetry C18 reverse-phase column
by a gradient method (water versus acetonitrile containing 0.1% trifluoroacetic
acid) and calculated based on absorbance values for purified standards diluted
into MOPS buffer.
Extraction and quantification of intracellular NADH and NAD. Extraction
of NADH and NAD was carried out according to the method described by San
et al. (58). Two 1-ml samples of culture were placed in two separate microcen-
trifuge tubes and centrifuged at 16,000  g for 1 min. Supernatant was removed,
and pellets were resuspended in 300 l of 0.2 M NaOH (for NADH extraction)
or 0.2 M HCl (for NAD extraction). These extracts were incubated for 10 min
at 50°C and then for 10 min on ice. While vortexing, 300 l of 0.1 M HCl (for
NADH) or 0.1 M NaOH (for NAD) was added dropwise to neutralize the
solutions. The samples were then centrifuged for 5 min at 16,000  g. Superna-
tants were transferred to fresh tubes and stored at 80°C until quantification.
Relative or absolute NADH and NAD were quantified using a modification
(58) of the enzyme cycling assay developed by Bernofsky and Swan (6), adapted
for measurement in a microtiter plate. A master reagent mix was prepared with
1 Bicine buffer (2.0 M, pH 8.0), 8 water, 1 80 mM EDTA, 2 100%
ethanol, 2 4.2 mM thiazolyl blue, and 4 16.6 mM phenazine ethosulfate. The
reagent mix was warmed to 30°C, and then 90-l aliquots were dispensed into
individual wells of a 96-well microtiter plate. Five microliters of standard or
sample was added to each well, and then the cycling reaction was started by the
addition of 5 l of alcohol dehydrogenase (Sigma no. A-3263) prepared at 347
units/ml in 0.1 M Bicine (pH 8.0). The microtiter plate was incubated at 30°C, the
contents were mixed by brief shaking, and the plate was read every 30 to 60
seconds for absorbance at 570 nm, which is the spectral peak of thiazolyl blue
that increases upon reduction. Slopes arising from plots of absorbance at 570 nm
over time were generated for NADH and NAD standards as well as for all
samples. Standard curves were used to calculate the absolute concentrations in
M, and values were normalized to the optical density of the original cell culture
sample.
Relative quantification of dissolved oxygen in batch cultures. Oxygen was
measured in batch fermentor cultures using a Clark electrode (11). The electrode
was calibrated such that the reading obtained by the computer without the probe
attached was equal to zero, while the initial reading for the uninoculated medium
(after aeration and agitation for 12 h) was set to 100 percent.
Analysis of small organic acids in culture filtrates. Two hundred microliters
was sampled from MOPS-glucose cultures (10 ml in an 18- by 150-mm test tube)
at regular intervals and filtered (0.2-m pore). In cases where repeated sampling
from the same culture would alter the total culture volume by more than 10%,
multiple identical cultures were inoculated from the same preculture and sam-
pled sequentially. Twenty microliters of each filtrate was loaded onto a Bio-Rad
Aminex HPX-87H column (300 by 7.8 mm) and subjected to an isocratic method
in 5 mM H2SO4 at 35°C, using a Waters HPLC system. Compounds were
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detected by UV absorbance at 210 nm. Absolute concentrations of pyruvate were
calculated using a standard curve for pyruvate diluted in MOPS buffer. The
identity of the pyruvate peak was verified by coelution of an internal standard.
RESULTS
P. aeruginosa PA14 catalyzes pyocyanin reduction. Station-
ary-phase LB cultures of P. aeruginosa PA14 turn bright blue-
green due to production of the blue pigment pyocyanin spe-
cifically during this growth phase. P. aeruginosa PA14 also
catalyzes the reduction of pyocyanin, a process that is readily
observed when a stationary-phase culture is left standing with-
out mixing or aeration by bubbling. Pyocyanin is converted
from its blue (oxidized) form to a colorless (reduced) form
(13). At the air-liquid interface, pyocyanin remains oxidized or
becomes reoxidized by an abiotic reaction with oxygen, but
respiration by the bacteria creates a steep oxygen gradient just
below this interface such that pyocyanin below a few millime-
ters remains colorless. A demonstration of this process is de-
picted in Fig. 1A (tube 3). We centrifuged a stationary-phase
culture, resuspended the cell pellet in a 100 M solution of
pyocyanin in MOPS buffer, and then allowed the culture to sit
without shaking for 5 min at room temperature. A gradient
formed that resembled those observed for cultures in growth
media. After vortexing, the entire suspension regained its orig-
inal blue color (Fig. 1A, tubes 5 and 6). A supernatant from
this suspension had the absorbance spectrum characteristic of
pyocyanin in the oxidation state most stable under atmospheric
conditions. When we moved the culture into an anaerobic
chamber and used a stoppered anaerobic cuvette to measure
the absorbance spectrum of anaerobic culture supernatant, the
sample showed decreased absorbance, indicating that pyocya-
nin had been reduced (Fig. 1B).
Pyocyanin reduction rates increase in stationary phase. To
quantify the rate of pyocyanin reduction by whole cells and test
whether this process, like the biosynthesis of phenazines, was
growth phase dependent, we sampled an LB culture at differ-
ent stages of growth. Samples were diluted into their own
supernatant, amended with pyocyanin, and transferred to an
anaerobic cuvette. We followed the decrease in oxidized pyo-
cyanin absorbance over time for each sample and observed a
marked increase in the rate of pyocyanin reduction after the
appearance of pyocyanin in stationary phase. This result indi-
cates that the rate of pyocyanin reduction by whole cells is
growth phase dependent (Fig. 2).
Pyocyanin exposure balances the intracellular redox state.
Strains of P. aeruginosa have been shown to vary in the timing
and extent of phenazine production relative to the growth
phase (9, 10, 18). We have observed that the appearance of
pyocyanin in wild-type P. aeruginosa PA14 LB cultures corre-
lates with entry into stationary phase and that pyocyanin pro-
duction plateaus in late stationary phase, reaching concentra-
FIG. 1. Stationary-phase P. aeruginosa PA14 cultures produce pyo-
cyanin and directly catalyze its reduction. (A) Tube 1, exponential-
phase LB culture; tube 2, stationary-phase LB culture, immediately
after removal from a shaking incubator; tube 3, stationary-phase LB
culture, left standing at room temperature for 5 min; tube 4, 100 M
pyocyanin in MOPS buffer, left standing at room temperature for 5
min; tube 5, same culture as in tubes 2 and 3, resuspended in buffer
shown in tube 4 and left standing at room temperature for 5 min;
tube 6, same suspension as in tube 5, after vortexing. (B) Absorbance
spectra of buffer and supernatants from panel A, tubes 4 to 6. The
suspension from tube 5 was centrifuged and placed in a stoppered
cuvette under anaerobic conditions. The pyocyanin/buffer spectrum
overlaps almost completely with that of the supernatant from the
aerated culture. PYO, pyocyanin. Supe., supernatant.
FIG. 2. The rate of pyocyanin reduction increases in stationary
phase in P. aeruginosa PA14. A 100-ml P. aeruginosa LB culture was
grown in a 500-ml Erlenmeyer flask and sampled at various points in
the growth curve. Cells were concentrated or diluted in culture super-
natant to normalize their optical density (600 nm) to 0.8, amended with
pyocyanin, and then transferred to anaerobic cuvettes and stoppered.
Absorbance at 690 nm was measured over time and was converted to
the amount of oxidized pyocyanin remaining in the cuvette. Gray
squares indicate time points at which samples were taken for cell
suspension assays. The black square indicates the first appearance of
pyocyanin in the culture. Data shown are representative of three sep-
arate experiments. OD, optical density; PYO, pyocyanin.
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tions ranging from 100 to 300 M, depending on the growth
conditions (Fig. 3A; see Fig. 4C).
Given that NADH reacts with pyocyanin in vitro (36), one
potential consequence of pyocyanin production and/or expo-
sure would be a decrease in intracellular NADH levels. We
tested this by growing cultures of wild-type P. aeruginosa and a
phz mutant (with in-frame deletions of both phenazine bio-
synthetic loci [18]) and measuring intracellular NAD(H) at
approximately 4 hours after the onset of stationary phase. The
intracellular NADH/NAD ratio in the wild type was less than
half that observed in the phz mutant. The growth curves for
these cultures were virtually identical under the incubation
conditions for this experiment (data not shown). Addition of
90 M oxidized pyocyanin (the approximate concentration of
pyocyanin produced by wild-type cultures under these condi-
tions) to phz mutant cultures reduced the NADH/NAD
ratio to the wild-type level (Fig. 3B). As a negative control,
supernatant from the phz mutant was extracted according to
the protocol for pyocyanin preparation and tested for an effect
on intracellular NAD(H) concentrations; no difference was
FIG. 3. Pyocyanin exposure effects redox balancing in stationary phase in a manner analogous to that of a known physiological electron
acceptor. (A) Growth and pyocyanin production for wild-type P. aeruginosa PA14 grown aerobically in 10 ml LB in 18- by 150-mm tubes.
(B) NADH/NAD ratios for cultures grown under the same conditions as those described for panel A. At 7 h, pyocyanin production in the
wild-type cultures was visible by eye; 45 M (half the expected final concentration) was added to the phz cultures to be tested for complemen-
tation, and 15 mM KNO3 was added to cultures to be tested for the effect of an additional electron acceptor. At 9 h, pyocyanin in the wild-type
cultures had increased to near-maximum concentrations, so a second dose of pyocyanin or KNO3 was added to the appropriate cultures, for final
concentrations of 90 M and 30 mM, respectively. Water was added to negative controls. At 11 hours after inoculation and 2 h after the addition
of the final dose of pyocyanin, NAD(H) was extracted and assayed for each culture. (C) NADH/NAD ratios for cultures treated as for panel B
but with various concentrations of pyocyanin added. (D) NADH and NAD concentrations for cultures described for panel B, normalized to
optical density (500 nm). Error bars represent the standard deviations from triplicate samples. OD, optical density; wt, wild type; PYO, pyocyanin.
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observed between cultures treated with “pyocyanin” prepara-
tions from the phz mutant and those treated with water (data
not shown). In titration experiments, an inverse relationship
was found to exist between the concentration of pyocyanin
added to a phz mutant culture and the NADH/NAD ratio
(Fig. 3C).
To test whether the effect of pyocyanin is similar to that of
a physiologically relevant terminal electron acceptor, we added
30 mM nitrate (a concentration sufficient to support growth of
P. aeruginosa via anaerobic nitrate respiration [70]) to a wild-
type culture and added nitrate with or without pyocyanin to
phz mutant cultures in stationary phase (Fig. 3B). Nitrate and
pyocyanin both effected decreases in intracellular NADH/
NAD ratios, apparently by catalyzing NADH oxidation, since
decreases in absolute NADH concentrations correlated with
increases in absolute NAD concentrations (Fig. 3D). Whereas
pyocyanin effected a decrease when added in the micromolar
range, nitrate did so only when added at millimolar concentra-
tions (data not shown). Together, these results suggested that
NADH can act as a source of electrons for pyocyanin reduction.
The intracellular NADH/NAD ratio is influenced by the
relative availability of electron donor and acceptor. Our ob-
servation that other electron acceptors, i.e., pyocyanin and
nitrate, decreased the NADH/NAD ratio suggested that ox-
ygen was limiting during stationary phase in our cultures. This
could explain the accumulation of NADH 4 hours after the
onset of stationary phase in the phz mutant (Fig. 3B). To
confirm this, we grew a batch culture of the phz mutant in a
fermentor, which allowed us to control temperature and aer-
ation while simultaneously measuring dissolved oxygen in the
culture. We sampled at regular intervals to measure optical
density and extract NAD(H). As predicted, oxygen levels de-
creased slowly until the culture reached mid- to late exponen-
tial phase, at which time it plummeted to zero. This drop in
oxygen correlated with an increase in the intracellular NADH/
NAD ratio (Fig. 4A). To test whether the drop in oxygen
depended on the availability of electron donors for oxygen
reduction, we repeated the experiment and added 20% of the
glucose concentration added to the medium in the initial ex-
periment (10 mM versus 50 mM). When less electron donor
was available, the oxygen concentration decreased in mid-ex-
ponential phase, but never reached zero, and rapidly increased
again upon entry into stationary phase (Fig. 4B). This culture
never reached the same growth yield achieved by the culture
containing 50 mM glucose, implying that the carbon source was
the limiting factor that led it to enter stationary phase. The
culture experienced oxygen limitation only transiently, if at all,
due to the lower ratio of electron donor to electron acceptor in
FIG. 4. NADH accumulates in stationary phase in cultures limited for oxygen and defective in pyocyanin production. P. aeruginosa wild-type
and phz cultures were grown in 1 liter of MOPS synthetic medium supplemented with either 50 or 10 mM glucose in a 3-liter fermentor with
constant aeration and agitation. Cultures were sampled at various points in the growth curve to allow measurement of the optical density at 500
nm and extraction of NAD(H). Relative dissolved oxygen concentrations were measured throughout growth using a polarographic oxygen
electrode. Optical density (500 nm), dissolved oxygen concentration, and NADH/NAD are shown for the phz mutant grown in medium
containing 50 mM glucose (A) and the phz mutant grown in medium containing 10 mM glucose (B). For panel C, showing wild-type P. aeruginosa
PA14 grown in medium containing 50 mM glucose, these parameters plus the concentration of pyocyanin produced by the culture are shown. OD,
optical density; PYO, pyocyanin; O2, dissolved oxygen.
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the experiment depicted in Fig. 4B compared to that in Fig.
4A. As a result, the NADH/NAD ratio never reached the
high level observed for the culture containing excess glucose.
Finally, we tested the wild-type strain in the presence of 50
mM glucose, and sampled for pyocyanin concentrations in
addition to NAD(H) and cell density. The wild-type strain also
exhibited increased NADH/NAD ratios upon entry into sta-
tionary phase, and these ratios correlated with oxygen limita-
tion. However, unlike the phz mutant, the wild type showed a
decrease in intracellular NADH/NAD that correlated with
the appearance of pyocyanin in the culture. These results fur-
ther support the hypothesis that pyocyanin can act as an alter-
nate oxidant under conditions where the terminal electron
acceptor for respiration has become limiting. This interpreta-
tion derives from the large difference in NADH/NAD ratios
observed between the wild-type strain and phz after about
12 h of incubation and the correlation between decreasing
NADH/NAD ratios and increasing pyocyanin concentrations
in culture filtrates observed upon entry into stationary phase
(Fig. 4C).
P. aeruginosa PA14 excretes, and then consumes, pyruvate in
late stationary phase. For fermentative organisms such as E.
coli and Propionibacterium freudenreichii, the addition of the
synthetic redox-cycling compound ferricyanide has been shown
to alter carbon flux through central metabolic pathways. Par-
ticularly when the reoxidation of this compound is coupled to
electron transfer to an electrode, ferricyanide shifted the fer-
mentation balance away from ethanol and propionate, prod-
ucts that require NADH for their formation, toward acetate, a
more oxidized product (19, 20). This implies that the ferricya-
nide acts as an electron shuttle from major pools of reductant
inside the cell, such as NADH, to the electrode, thereby less-
ening the need for formation of more reduced fermentation
products to dissipate cellular reductant.
To determine whether pyocyanin could play a similar role in
P. aeruginosa, we analyzed filtered culture supernatants for
small organic acids that are known fermentation products of P.
aeruginosa metabolism. P. aeruginosa has been shown to fer-
ment pyruvate under energy-starved conditions, converting it
to lactate, acetate, and/or succinate. The production of lactate
or succinate from pyruvate requires NADH as a substrate,
while the conversion of pyruvate to acetate requires NAD
(21). Therefore, the NADH/NAD ratio in the wild type
would be more favorable for acetate production, whereas the
NADH/NAD ratio in the phz mutant would favor produc-
tion of lactate and succinate.
Surprisingly, we observed a marked difference between the
wild type and the phz mutant with respect to the production
of pyruvate itself. In late stationary phase (about 30 h after
inoculation) after growth in a defined medium with 50 mM
glucose, we observed pyruvate concentrations as high as 6 mM
in wild-type culture filtrates (as indicated by a peak eluting at
about 10.5 min) but were unable to detect any pyruvate in
filtrates from phz mutant cultures. Adding pyocyanin to the
phz mutant upon entry into stationary phase complemented
the pyruvate excretion phenotype (Fig. 5), although incom-
pletely because we added only about half the final concentra-
tion of pyocyanin produced by the wild type under these con-
ditions (50 versus 100 M). We also detected citrate, lactate,
and acetate in both wild-type and phz mutant culture filtrates
FIG. 5. Wild-type P. aeruginosa PA14 excretes pyruvate in stationary phase, and addition of pyocyanin to phz mutant cultures restores the
pyruvate excretion phenotype. Cultures were inoculated into MOPS synthetic medium amended with 50 mM glucose (initial optical density at 500
nm, 0.03). To complement pyruvate excretion, 50 M pyocyanin was added to the phz culture at the time when pyocyanin reached its maximum
concentration in the wild-type cultures (approximately 12 h after inoculation). Twenty microliters of culture filtrates at the 24-hour time point was
loaded onto an anion-exchange column and subjected to an isocratic gradient in 5 mM H2SO4. Pyruvate peaks are indicated by arrows. The elution
time of pyruvate drifts slightly but averages around 10.5 min. Results shown are representative of three separate experiments. Other peak identities
are described in the text. wt, wild type; PYO, pyocyanin.
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at similar concentrations, eluting at 9.1, 14.3, and 17.0 min,
respectively. The peak eluting at 7.1 min was the MOPS buffer
from the medium. We were unable to identify the compounds
represented by the peaks eluting at approximately 7.3 min
(wild-type filtrate only) and at 9.9 and 12.2 min (both wild-type
and phz mutant filtrates). Standards containing 2-oxogluta-
rate and malate were run with the same method but did not
coelute with any of these peaks.
To better constrain the timing of metabolite excretion in the
wild type and the phz mutant, we sampled every 4 h from
duplicate cultures over the course of approximately 30 h in
stationary phase (Fig. 6). Pyruvate appeared at detectable lev-
els in wild-type cultures at between 22 and 26 h after inocula-
tion and had increased to 5 mM after 38 h. However, by the
42-hour time point, the pyruvate in both replicates had de-
creased to levels below the detection limit (0.05 mM) (Fig.
6C). Abiotic degradation of pyruvate generates a peak eluting
at approximately 8 min, which does not coelute with any of the
peaks observed in traces from our culture filtrates (data not
shown). Therefore, the disappearance of the pyruvate peak at
the 42-hour time point implied that it had been metabolized by
the bacteria.
Another phenotype that became apparent under these
growth conditions was the reproducible difference in cell yields
between wild-type and phz mutant cultures. The optical den-
sities of wild-type cultures were typically lower than those of
the phz mutant cultures in stationary phase, a phenotype that
becomes more apparent when the optical density is plotted on
a linear scale (Fig. 6A and B).
Pyruvate fermentation facilitates survival in energy-starved
P. aeruginosa PA14 cultures. Recently, Schobert and col-
leagues have characterized genes implicated in a pyruvate fer-
mentation pathway in P. aeruginosa strain PAO1 (21, 59). In
this pathway, pyruvate is converted by multiple enzymes to
succinate, acetate, and/or lactate. We do not suspect that these
reactions were responsible for the consumption of pyruvate in
late stationary phase in our cultures, because these compounds
are detectable by our analytical HPLC method, and we did not
see their concentrations increase as pyruvate disappeared
(data not shown). We therefore hypothesize that pyruvate was
completely oxidized through the utilization of the small
amount of oxygen available to the cells. However, in environ-
ments with steep gradients of electron acceptor availability,
such as those encountered in surface-attached or aggregated
bacterial communities, excreted pyruvate may be utilized for
substrate-level phosphorylation when respiratory electron ac-
ceptors become limiting. To verify that P. aeruginosa strain
PA14 can utilize pyruvate for survival under strict anaerobic
conditions, we incubated the wild type and an ldhA mutant,
defective in the ability to reduce pyruvate to lactate, in stop-
pered serum bottles containing buffered LB amended with 20
mM pyruvate. As a control, we set up a wild-type culture with
no pyruvate. We followed CFU in samples from these cultures
over more than 3 weeks and found that, as had been previously
reported for P. aeruginosa PAO1 (21, 59), a mutant with a
disruption in the gene ldhA was defective in survival on pyru-
vate (see Fig. S1 in the supplemental material). The decline of
this mutant was similar to that of the wild-type culture con-
taining no added pyruvate. P. aeruginosa PA14 is therefore also
able to survive under conditions of energy starvation through
FIG. 6. P. aeruginosa PA14 cultures consume excreted pyruvate in
very late stationary phase. Duplicate cultures were inoculated at an
optical density (500 nm) of 0.001 in MOPS synthetic medium
amended with 50 mM glucose. Approximately every 4 h, 100 to 200 l
of culture was sampled and filtered for HPLC analysis as described for
Fig. 5. (A) Optical density at 500 nm for wild-type and phz cultures
plotted on a logarithmic scale. (B) same data as in panel A plotted on
a linear scale to show the lower growth yields consistently observed for
wild-type PA14 under this condition. (C) Quantification of pyruvate
production for the “wt 1” and “wt 2” cultures. Inset, chromatograms
demonstrating the disappearance of pyruvate at 42 h for the “wt 1”
culture. The arrow indicates the elution time of the pyruvate peak.
OD, optical density; wt, wild type.
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utilization of a lactate dehydrogenase-dependent pathway for
pyruvate fermentation.
DISCUSSION
In this study, we have characterized the effects of a station-
ary-phase-specific metabolite on the carbon and energy metab-
olism of P. aeruginosa cultures. Metabolites formed in station-
ary phase historically have been categorized as products of
“secondary” forms of metabolism that bear little relevance to
energy generation. However, we have shown that the redox
activity of pyocyanin, a phenazine produced after the exponen-
tial phase of growth in batch cultures, affects the metabolic
status of its producer. Bacteria such as the pseudomonads, with
limited capacities for fermentation, are generally thought to
depend on terminal electron acceptors, and on the function of
their membrane-bound respiratory chains, for the ability to
maintain a balanced intracellular redox state. The redox-bal-
ancing effect of pyocyanin may be particularly important in
bacterial communities limited for oxygen, an electron acceptor
whose uptake rate outpaces its diffusion rate through dense
cultures of respiring bacteria (63, 75).
As part of our characterization of the physiological effects of
pyocyanin reduction in P. aeruginosa, we found that pyocyanin
reductive activity in whole cells increases after entry into sta-
tionary phase and the appearance of phenazines in batch cul-
tures (Fig. 2). While we cannot rule out that this increase is due
merely to an increase in the concentration of the electron
donor for this reaction, we know that pyocyanin induces ex-
pression of genes encoding multidrug efflux pumps and oxi-
doreductases that could be involved in the redox cycling of this
compound (18). Such gene products may contribute to the
observed increase in the pyocyanin reduction rate. We also
found that pyocyanin exposure in stationary-phase cultures
decreases the intracellular NADH/NAD ratio (Fig. 3). The
increase in the NADH/NAD ratio that we observe for a
mutant defective in phenazine production correlates with ox-
ygen limitation (Fig. 4) and is relieved by the presence of
pyocyanin (Fig. 3), suggesting that pyocyanin plays a role in
redox balancing.
Given that the reduction of pyocyanin by NADH is a ther-
modynamically favorable reaction, one could attribute the ob-
served inverse relationship between intracellular [NADH] and
pyocyanin production (Fig. 4C) to a model such as that shown
in Fig. 7. In this model, stationary-phase cells accumulate
NADH as a consequence of oxygen limitation (Fig. 7A) and
transfer electrons to pyocyanin when it becomes available (Fig.
7B). Pyocyanin can subsequently be reoxidized through abiotic
electron transfer to oxygen. Differences in central metabolism
depending on the presence or absence of synthetic and envi-
ronmental electron shuttles have been reported for fermenta-
tive bacteria (5, 19, 20) and apparently arise from the effects of
extracellular electron shuttling on the intracellular redox state.
If the mechanism of redox balancing depicted in Fig. 7B were
operational, we might expect a phenazine-null mutant (lacking
the naturally produced pseudomonad electron shuttle) to be
defective in complete oxidation of its carbon source, since flux
through the citric acid cycle would be inhibited by a relatively
reduced NAD(H) pool. Instead, we observed that the wild-
type strain appears to be affected in its ability to mineralize its
carbon source, based on the excretion of pyruvate in late sta-
tionary phase (Fig. 5 and 6). This phenomenon thus suggests
an alternative mechanism for lowering the NADH/NAD ra-
tio, in which NADH accumulation is avoided in the wild type
by excretion of pyruvate before it can enter the citric acid cycle
and reduce NAD (Fig. 7C). Because stationary-phase P.
aeruginosa cells both catalyze pyocyanin reduction and excrete
pyruvate, maintenance of redox homeostasis in stationary-
phase P. aeruginosa PA14 could be due to a combination of the
mechanisms shown in Fig. 7B and C.
FIG. 7. Model for how pyocyanin reduction allows P. aeruginosa
PA14 to maintain redox homeostasis under oxygen-limited conditions.
When sufficient oxygen is available for growth (A), the aerobic respiratory
chain (“resp”) can catalyze the reoxidation of NADH. Under conditions
in which terminal electron acceptors for respiration are limiting (B), P.
aeruginosa can couple the reoxidation of NADH to the reduction of
pyocyanin, either directly or through an enzyme-mediated reaction as
represented by “PYO red,” a putative phenazine reductase. The electrons
could be transferred from pyocyanin to oxygen through an abiotic extra-
cellular reaction. (C) Also under conditions of oxygen limitation, the
NADH/NAD ratio could be balanced through inactivation of the pyru-
vate dehydrogenase complex by pyocyanin. NAD reduction (and there-
fore NADH production) would be avoided because pyruvate would be
excreted without further oxidation. PYO, pyocyanin.
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Although pyruvate excretion has been observed in cultures
of other bacteria, such as Aerobacter aerogenes and Photobac-
terium fischeri (since reclassified as members of Enterobacter
and Vibrio, respectively), the mechanisms underlying its regu-
lation have not been elucidated (57, 68). An understanding of
the pyruvate oxidation machinery in pseudomonads provides
insight into the potential mechanisms whereby this reaction
may be inhibited in pyocyanin-producing cells. The conversion
of pyruvate to acetyl coenzyme A (acetyl-CoA) is catalyzed by
pyruvate dehydrogenase, a large multienzyme complex preva-
lent during aerobic growth in bacteria and eukarya, though
there is some evidence for its occurrence in archaea as well
(34). All pyruvate dehydrogenase multienzyme complexes re-
quire dihydrolipoamide, a cofactor which is covalently bound
to the E2 subunit, to transfer an acyl group derived from
pyruvate to CoA and produce acetyl-CoA. Dihydrolipoamide
contains a disulfide bond that is broken and reformed during
the three-step pyruvate decarboxylation and oxidation mecha-
nism (14, 17). The one-electron reduction of each suflhydryl
group of the lipoamide cofactor on the E2 subunit, catalyzed
by superoxide (8, 64), is thought to inactivate the enzyme. The
generation of superoxide by pyocyanin, or even the formation
of pyocyanin radical itself (29), may therefore inhibit the pyru-
vate dehydrogenase complex, leading to accumulation of pyru-
vate.
Regardless of whether the excretion of pyruvate by wild-type
P. aeruginosa results from an apparently toxic side reaction, it
may be beneficial under pyocyanin-producing conditions. Ex-
creted pyruvate that remains in the immediate environment
could potentially be accessed later during a “last gasp” under
conditions of extreme energy starvation. While this scenario is
unlikely to occur in the soil, where other microorganisms might
consume the pyruvate before it was metabolized by the pro-
ducer, it may be relevant for conditions encountered by P.
aeruginosa during chronic infection of the lung. Individuals
with chronic P. aeruginosa infections resulting from impaired
lung function harbor monocultures of this bacterium at cell
densities of as high as 107 CFU/g sputum (43). It is thought
that bacteria in the lung cavity experience steep gradients of
electron acceptor availability (74), and the ability to reserve a
pool of substrate or transfer it to an energy-starved neighbor
may contribute to the ability of P. aeruginosa populations to
persist throughout the lifetime of the individual host (59).
Pseudomonad phenazines as well as other high-cell-density
signals have been detected in the sputa of chronically infected
patients (60, 72). An interesting avenue for future research,
therefore, is to determine whether the physiological effects of
pyocyanin on P. aeruginosa contribute to its long-term survival
during chronic colonization of the lung.
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